Induced ketosis as a treatment for neuroprogressive disorders: food for thought?
In this article, Morris et al. (2020) explain the mechanisms by which induced ketosis might reduce mitochondrial dysfunction, inflammation, and oxidative stress in neuropsychiatric disorders, and may be able to ameliorate abnormal levels of molecules and signaling pathways that appear to contribute to the pathophysiology of disorders such as schizophrenia, bipolar disorder, and major depressive disorder. In addition, the authors examine the safety data relating to induced ketosis over the long term and discuss future study design. [NPID: mood disorders, psychiatric disorders, ketosis, ketones, ketogenic diet, keto, mitochondrial dysfunction, inflammation, oxidative stress, major depressive disorder, MDD, bipolar disorder, BD]
Year: 2020
Reference: Morris, G., Puri, B. K., Carvalho, A., Maes, M., Berk, M., Ruusunen, A., & Olive, L. (2020). Induced Ketosis as a Treatment for Neuroprogressive Disorders: Food for Thought?. The international journal of neuropsychopharmacology, 23(6), 366–384. https://doi.org/10.1093/ijnp/pyaa008
Related Studies
The cause of bipolar disorder (BPD), a crippling mental disease, remains unknown. A deeper comprehension of its underlying physiological mechanisms is crucial for identifying new avenues for treatment enhancement and preventative measures. This study by Stacey et al. (2024) employs metabolome-wide Mendelian randomization to explore metabolites potentially linked to BPD causality. The authors examined 913 […]
In this article, Akhondzadeh (2019) briefly reviews data that suggest that the microbiome may improve our understanding of schizophrenia. While antipsychotic treatments exist, they have effectiveness and safety limitations, and lack the capacity to treat the negative symptoms of schizophrenia as effectively as antipsychotics used for positive symptoms. Researchers have identified a subset of bacteria […]